315 related articles for article (PubMed ID: 20467370)
1. Pediatric aspects in Graves' orbitopathy.
Gogakos AI; Boboridis K; Krassas GE
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
[TBL] [Abstract][Full Text] [Related]
2. Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.
Krassas GE; Gogakos A
J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1193-206. PubMed ID: 17172081
[TBL] [Abstract][Full Text] [Related]
3. [Graves' orbitopathy].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
[TBL] [Abstract][Full Text] [Related]
4. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
5. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
6. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
7. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
8. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
9. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Azzam I; Tordjman K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
[TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations in children and adolescents with thyrotoxicosis.
Grüters A
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S172-4. PubMed ID: 10614915
[TBL] [Abstract][Full Text] [Related]
11. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
12. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
13. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for Graves' orbitopathy.
Marcocci C; Altea MA; Leo M
Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
[TBL] [Abstract][Full Text] [Related]
16. Thyroid associated ophthalmopathy: pediatric and endocrine aspects.
Wiersinga WM
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():513-7. PubMed ID: 16444185
[TBL] [Abstract][Full Text] [Related]
17. Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors.
Krassas GE; Perros P
Pediatr Endocrinol Rev; 2007 Mar; 4(3):218-24. PubMed ID: 17551483
[TBL] [Abstract][Full Text] [Related]
18. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients.
Baldeschi L; Wakelkamp IM; Lindeboom R; Prummel MF; Wiersinga WM
Ophthalmology; 2006 May; 113(5):874-8. PubMed ID: 16530839
[TBL] [Abstract][Full Text] [Related]
19. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.
Krassas GE
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():223-9; discussion 229. PubMed ID: 16444162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
